Publication: Comparison of methotrexate and Azathioprine as the first steroid-sparing immunosuppressive agent in patients with Takayasu's Arteritis
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Kaymaz-Tahra, Sema
Tsechelidis, Ozun Bayindir
Ince, Burak
Isik, Ozlem Ozdemir
Kutu, Muhammet Emin
Karakas, Ozlem
Yildirim, Tuba Demirci
Ademoglu, Zeliha
Ediboglu, Elif Durak
Uludogan, Burcu Ceren Ekti
Date
Language
Type
Embargo Status
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Background Conventional disease-modifying anti-rheumatic drugs (cDMARDs) are recommended in addition to glucocorticoids (GC) for all active Takayasu's arteritis (TAK) patients as the first-line therapy.However, there is limited data comparing cDMARDs as the first-line immunosuppressive (IS) treatment. Objectives In this study, we aimed to compare the outcomes of methotrexate (MTX) and azathioprine (AZA), which were used most frequently as the first-line cDMARDs in TAK patients.
Source
Publisher
Elsevier
Subject
Citation
item.page.haspartof
Source
Arthritis and Rheumatology
item.page.ispartofseries
item.page.edition
DOI
10.1136/annrheumdis-2023-eular.6172